Kristin Myers - Mar 18, 2025 Form 4 Insider Report for Arcellx, Inc. (ACLX)

Role
Director
Signature
/s/ Michelle Gilson, as Attorney-in-Fact
Stock symbol
ACLX
Transactions as of
Mar 18, 2025
Transactions value $
$0
Form type
4
Date filed
3/20/2025, 05:16 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACLX Stock Option (right to buy) Award $0 +16.8K $0.00 16.8K Mar 18, 2025 Common Stock 16.8K $69.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the shares subject to the option will vest each year following the Equity Grant Date on the same day of the month as the Equity Grant Date (or, if there is no corresponding day in a particular month, then the last day of the month) over three (3) years. "Equity Grant Date" shall mean March 18, 2025.